Control in Biological Systems

The field of control and systems has been connected to biological systems and biotechnology for many decades, going back to the work of Norbert Wiener on cybernetics in 1965, the work of Walter Cannon on homeostasis in 1929, and the early work of Claude Bernard on the milieu interieur in 1865. Nonetheless, the impact of control and systems on devices and applications in the field of biology has only emerged in recent years.

[1]  G. Zajicek,et al.  The Wisdom of the Body , 1934, Nature.

[2]  A H Clemens,et al.  The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[3]  A H Clemens,et al.  Feedback control dynamics for glucose controlled insulin infusion system. , 1979, Medical progress through technology.

[4]  A. Albisser,et al.  Devices for the control of diabetes mellitus , 1979, Proceedings of the IEEE.

[5]  A. M. Albisser,et al.  Comparison of Algorithms for the Closed-Loop Control of Blood Glucose Using the Artificial Beta Cell , 1981, IEEE Transactions on Biomedical Engineering.

[6]  L. Geddes,et al.  Historical highlights in cardiac pacing , 1990, IEEE Engineering in Medicine and Biology Magazine.

[7]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[8]  Michael C. K. Khoo,et al.  Physiological Control Systems: Analysis, Simulation, and Estimation , 1999 .

[9]  James F. Antaki,et al.  Control system architecture for mechanical cardiac assist devices , 2000, Proceedings of the 2000 American Control Conference. ACC (IEEE Cat. No.00CH36334).

[10]  James F. Antaki,et al.  Control issues in rotary heart assist devices , 2000, Proceedings of the 2000 American Control Conference. ACC (IEEE Cat. No.00CH36334).

[11]  S. Schraag,et al.  Theoretical basis of target controlled anaesthesia: history, concept and clinical perspectives , 2001 .

[12]  Mikhail Skliar,et al.  Nonlinear controller for ventricular assist devices. , 2002, Artificial organs.

[13]  Steven L Shafer,et al.  Target-controlled Infusions for Intravenous Anesthetics Surfing USA Not ! , 2003 .

[14]  Roman Hovorka,et al.  Closing the loop: the adicol experience. , 2004, Diabetes technology & therapeutics.

[15]  Roman Hovorka,et al.  Multicentric, Randomized, Controlled Trial to Evaluate Blood Glucose Control by the Model Predictive Control Algorithm Versus Routine Glucose Management Protocols in Intensive Care Unit Patients , 2006, Diabetes Care.

[16]  Francis J. Doyle,et al.  Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus , 2006, IEEE Transactions on Biomedical Engineering.

[17]  S.A.P. Haddad,et al.  The evolution of pacemakers , 2006, IEEE Engineering in Medicine and Biology Magazine.

[18]  Georg Wieselthaler,et al.  First clinical experience with an automatic control system for rotary blood pumps during ergometry and right-heart catheterization. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[20]  Garry M. Steil,et al.  Automated insulin delivery for type 1 diabetes , 2006 .

[21]  B. Bequette,et al.  A tutorial on biomedical process control , 2007 .

[22]  B. Wayne Bequette III. Modeling and control of drug infusion in critical care , 2007 .

[23]  G. W. Swan Optimal control applications in biomedical engineering—a survey , 2007 .

[24]  Howard C. Zisser,et al.  Prandial Insulin Dosing Using Run-to-Run Control , 2007, Diabetes Care.

[25]  Eyal Dassau,et al.  Safety constraints in an artificial β-cell : an implementation of Model Predictive Control ( MPC ) with Insulin-on-Board ( IOB ) , 2008 .

[26]  Eyal Dassau,et al.  Bolus calculator: a review of four "smart" insulin pumps. , 2008, Diabetes technology & therapeutics.

[27]  P J Manberg,et al.  Regulatory Challenges Facing Closed‐Loop Anesthetic Drug Infusion Devices , 2008, Clinical pharmacology and therapeutics.

[28]  L. Mofenson,et al.  Pharmacokinetics and Pharmacodynamics of Efavirenz and Nelfinavir in HIV‐infected Children Participating in an Area‐under‐the‐curve Controlled Trial , 2008, Clinical pharmacology and therapeutics.

[29]  B. Goudra,et al.  Target-controlled infusions/patient-controlled sedation , 2009 .

[30]  Gordon Ellis,et al.  Grand challenges for engineering , 2009, IEEE Engineering Management Review.

[31]  Eyal Dassau,et al.  In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. , 2009, Diabetes technology & therapeutics.

[32]  Janet M. Allen,et al.  Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial , 2010, The Lancet.

[33]  Robert G. Sutherlin,et al.  A Bihormonal Closed-Loop Artificial Pancreas for Type 1 Diabetes , 2010, Science Translational Medicine.